JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brixius, K.
Right arrow Articles by Schwinger, R. H. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brixius, K.
Right arrow Articles by Schwinger, R. H. G.

Vol. 295, Issue 3, 1284-1290, December 2000

Different Effect of the Ca2+ Sensitizers EMD 57033 and CGP 48506 on Cross-Bridge Cycling in Human Myocardium1

Klara Brixius, Uwe Mehlhorn, Wilhelm Bloch and Robert H. G. Schwinger

Laboratory of Muscle Research and Molecular Cardiology, Clinic III of Internal Medicine (K.B., R.H.G.S.), Clinic of Cardiothoracic Surgery (U.M.), and Institute I of Anatomy (W.B.), University of Cologne, Köln, Germany

Ca2+ sensitizers may be advantageous for treatment in human heart failure by increasing cardiac force without increasing the Ca2+ transient or energy consumption. To study the mode of action of the Ca2+ sensitizers EMD 57033 (EMD) and CGP 48506 (CGP), their influence on butanedione monoxime (BDM)-mediated depression of cross-bridge cycling was analyzed in human myocardium (explanted hearts, dilated cardiomyopathy, n = 19). In Triton X (1%)-skinned fiber preparations of left ventricular myocardium from patients suffering from dilated cardiomyopathy, troponin I was extracted by vanadate (10 mM) treatment, resulting in a Ca2+-independent contraction. In troponin I-depleted fibers BDM (5-50 mM) was applied in the absence and presence of EMD (10 µM) or CGP (10 µM). To analyze the influence on cross-bridge kinetics, tension cost (ratio of ATPase activity and tension development) was studied. BDM exerted a dose-dependent force inhibition in troponin I-depleted fibers (IC50 = 7.22 mM), which was antagonized by EMD (IC50 of BDM + EMD = 19.97 mM) and CGP (IC50 of BDM + CGP = 15.30 mM). EMD increased Ca2+ sensitivity of force and maximal force in Triton X-skinned fibers. The Ca2+-sensitizing effect of CGP was accompanied by an increased Ca2+ sensitivity of myosin-ATPase activity, an increased slope of the Ca2+ force and Ca2+ ATPase curve, as well as a reduced maximal myosin ATPase activity. CGP and EMD reduced tension cost. In conclusion, EMD and CGP antagonize the BDM-mediated relaxation in troponin I-depleted cardiac muscle fibers. The Ca2+-sensitizing effect of CGP seems to be dependent on an improvement of the myofilament cooperativity, whereas EMD seems to operate by increasing the force per cross-bridge.


1 This work was supported by Deutsche Forschungsgemeinschaft (R.H.G.S.) and Köln Fortune (K.B.).


0022-3565/00/2953-1284$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Cardiovasc ResHome page
Z. Chen, W. Huang, T. Dahme, W. Rottbauer, M. J. Ackerman, and X. Xu
Depletion of zebrafish essential and regulatory myosin light chains reduces cardiac function through distinct mechanisms
Cardiovasc Res, July 1, 2008; 79(1): 97 - 108.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Frey, K. Brixius, R. H. G. Schwinger, T. Benis, A. Karpowski, H. P. Lorenzen, M. Luedde, H. A. Katus, and W. M. Franz
Alterations of Tension-dependent ATP Utilization in a Transgenic Rat Model of Hypertrophic Cardiomyopathy
J. Biol. Chem., October 6, 2006; 281(40): 29575 - 29582.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L. B. Stull, M. K. Leppo, L. Szweda, W. D. Gao, and E. Marban
Chronic Treatment With Allopurinol Boosts Survival and Cardiac Contractility in Murine Postischemic Cardiomyopathy
Circ. Res., November 12, 2004; 95(10): 1005 - 1011.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. G. Soergel, D. Georgakopoulos, L. B. Stull, D. A. Kass, and A. M. Murphy
Augmented systolic response to the calcium sensitizer EMD-57033 in a transgenic model with troponin I truncation
Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1785 - H1792.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Communal, M. Sumandea, P. de Tombe, J. Narula, R. J. Solaro, and R. J. Hajjar
Functional consequences of caspase activation in cardiac myocytes
PNAS, April 30, 2002; 99(9): 6252 - 6256.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Communal, M. Sumandea, P. de Tombe, J. Narula, R. J. Solaro, and R. J. Hajjar
Functional consequences of caspase activation in cardiac myocytes
PNAS, April 30, 2002; 99(9): 6252 - 6256.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.